NCI's Division of Cancer Prevention will present a week-long course in molecular prevention August 2-6. See http://www3.cancer.gov/ prevention/pob/courses/ molprev.html for more information and to register.

RFA HL-04-034
Letter of Intent Receipt Date: Jan. 16, 2005
Application Receipt Date: Feb. 16, 2005

This RFA solicits applications for research to identify new cellular and genetic markers associated with the origin and progression of myeloproliferative disorders (MPD) that can be applied to the future development of novel therapeutics with curative intent. MPDs represent a broad range of clinical entities, which creates difficulties in prompt assignment of diagnosis, prediction of prognosis, characterization of disease evolution, and research on the etiology and progression of disease.

This RFA will use the R01 award mechanism.

For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2101

Inquiries: Dr. R. Allan Mufson, am214t@nih.gov

Reducing Barriers to Symptom Management and Palliative Care

RFA-CA-05-013
Letter of Intent Receipt Date: Aug. 24, 2004
Application Receipt Date: Sept. 24, 2004

This RFA is to solicit applications for research directed at developing and testing interventions to reduce or overcome barriers to the delivery of appropriate symptom management and palliative care for persons living with cancer, thereby decreasing suffering and improving health and quality of life. Relative research should: 1) generate knowledge about how to reduce barriers to delivery of symptom management and palliative care, 2) address barriers for vulnerable, medically underserved, and special populations to access and receive palliative care, and 3) encourage research collaborations across disciplines.

This RFA will use NIH R01 (research project grant) and R21 (exploratory/developmental grant) award mechanisms.

For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2100

Inquiries: Dr. Ann O'Mara, omaraa@mail.nih.gov